Embolization coils market is expected to reach US$ 1,591.60 million by 2028 from US$ 1,191.78 million in 2021. It is estimated to grow at a CAGR of 4.3% during 2022–2028.
Embolization coils are used to treat brain and cardiac aneurysms and other blood-related conditions. They are used as an alternative to surgical embolization to cut the blood supply to the tumor. It is used to treat various types of diseases, such as liver cancer, kidney cancer, aortic artery disorders, neuroendocrine tumors, and peripheral vascular diseases.
Download sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPHE100001434/
Terumo Corporation; Medtronic plc; Boston Scientific Corporation; Stryker Corporation; Johnson & Johnson; Cook Medical; Penumbra, Inc.; Kaneka Corporation; Shape Memory Medical INC.; and Microport Scientific Corporation are among the leading companies operating in the global embolization coils market. In August 2022, Boston Scientific Corporation BSX announced the acquisition of Obsidio, Inc. It is a privately held company and the renowned developer of the FDA-authorized Gel Embolic Material (GEM) technology.
In November 2021, Pfizer Inc. announced the investigational COVID-19 oral antiviral candidate, PAXLOVID. Based on an interim analysis of the Phase 2/3 Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients (EPIC-HR), a randomized, double-blind study of non-hospitalized adult COVID-19 patients who were at a high risk of progressing to severe illness, the PAXLOVID vaccine reportedly reduced hospitalization and death. There were supply constraints related to vaccine production in the initial months of 2021. However, setting up new plants and promoting technological shifts are the strategies that support the production of booster doses in the US and Canada, along with their administration plans.
Inquiry Before Buying at: https://www.theinsightpartners.com/inquiry/TIPHE100001434/
Embolization coils are used to treat brain and cardiac aneurysms and other blood-related conditions. This is used as an alternative to surgical embolization to cut the blood supply to the tumor. It is used to treat various types of diseases, such as liver cancer, kidney cancer, aortic artery disorders, neuroendocrine tumors, and peripheral vascular diseases. The cost of overall healthcare is surging significantly in North America. The US health system incurred a direct cost of US$ 5.3 billion in 2020. The healthcare system contributed US$ 60 billion in addition to the overall annual costs of the country in 2020. Over 40% of the population in North America canceled their appointments in 2020, and 13% of them reported that they needed care but did not schedule or receive care. The COVID-19 pandemic altered economic conditions and social behaviors in North American countries. Containment measures enacted by governments to mitigate the disease spread changed the pattern of healthcare service delivery in the US. According to the Department of Emergency Medicine, in many cities across the country, emergency department (ED) visits decreased by ~40% in 2020. Moreover, outpatient appointments and elective treatments were postponed or replaced by telemedicine practices.
The report highlights the key factors driving the embolization coils market and prominent players with their developments in the global embolization coils market. Key factors driving the market are rise in the prevalence of cardiac aneurysms, increase in the incidence of cancer cases, rise in patient preference for minimally invasive procedures, and surge in the incidence of hypertension, obesity, smoking, and alcoholism. However, the high cost of embolization coils and numerous product recalls are expected to restrict the market growth during the forecast period.
Based on end user, the market is segmented into hospital, cardiac center, ambulatory center, and others. Based on geography, the global embolization coils market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPHE100001434/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876